Alex Denner's firm takes over Amarin, ousts non-Sarissa board members
Activist investor Alex Denner has now solidified his control over Irish drugmaker Amarin.
In the wake of last week’s shareholder election that saw Denner’s VC Sarissa Capital Management install seven directors on Amarin’s board, the company announced Monday afternoon that the seven non-Sarissa board members are exiting from their positions “to avoid further proxy contests.”
Murray Stewart, a former CMO at GSK who was added to Amarin’s board just earlier this year and was a catalyst that led to the vote, is also leaving the board.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.